基于《黄帝内经》“水郁折之”理论探讨糖尿病肾病
Discussion on Diabetic Nephropathy Based on the Theory of “Shui Yu Zhe Zhi” in Huangdi Neijing
DOI: 10.12677/tcm.2026.152104, PDF,   
作者: 胡 华*:成都中医药大学临床医学院,四川 成都;陈 秋#:成都中医药大学附属医院内分泌科,四川 成都
关键词: 糖尿病肾病水郁折之肾络理论中西医结合Diabetic Nephropathy Shui Yu Zhe Zhi Kidney Collateral Theory Combination of Chinese and Western Medicine
摘要: 作为糖尿病主要微血管并发症,糖尿病肾病的病理表现为蛋白尿、水肿及肾功能进行性下降。基于《黄帝内经》“水郁折之”理论,提出糖尿病肾病“肾阳亏虚为本,水湿郁滞–肾络瘀阻为标”的核心病机,并强调其病机演变具有糖浊内蕴、痰瘀胶结的糖尿病特异性。水郁本质为肾阳气化失司,并与肝、脾、肺、膀胱等多脏腑协同失调密切相关,最终形成“水郁–络瘀”恶性循环。治疗以温肾化气消水郁之源,疏肝理气调气机之枢,健脾制水绝湿浊之生,宣肺利水通水道之壅,开利膀胱助三焦气化,化痰逐瘀通肾络之痹。结合现代药理学证据(如真武汤兴奋下丘脑–垂体轴、五苓散调控肾素–血管紧张素–醛固酮系统),阐明“以脏为纲、以郁为机、以通为用”的治疗理念,并通过临床案例分析佐证理论应用,为糖尿病肾病的中西医结合临床管理提供新思路。
Abstract: As a major microvascular complication of diabetes mellitus, diabetic nephropathy is characterised by proteinuria, oedema and progressive decline in renal function. Based on the theory of “Shui Yu Zhe Zhi” in Huangdi Neijing, the core pathogenesis of diabetic nephropathy is ‘deficiency of kidney yang as the root cause, stagnation of water and dampness - stagnation of renal collaterals as the symptom’. It emphasizes that the pathological evolution of DN is specific to diabetes, featuring internal accumulation of glucose-turbidity and intertwining of phlegm and stasis. The essence of water stagnation lies in the failure of kidney yang in qi transformation, closely related to the dysfunction of multiple organs such as the liver, spleen, lungs, and bladder, ultimately forming a vicious cycle of “water stagnation - collateral stasis”. The treatment is to warm the kidneys to eliminate the source of water depressions, dredge the liver to regulate qi and regulate the pivot of qi, strengthen the spleen to control water to stop the birth of dampness and turbidity, promote the lungs to relieve the congestion of the watercourses, open up the urinary bladder to support the vitality of the three visceral cavities, and dissolve phlegm and expel blood stasis to relieve the paralysis of the kidney complexes. Combined with modern pharmacological evidence (e.g. Zhenwu Tang excites the hypothalamic-pituitary axis, Wu Ling San regulates the renin-angiotensin-aldosterone system), the treatment concept of “taking the organ as the outline, depression as the mechanism, and communication as the function” is clarified, and the application of the theory is supported by clinical case studies, which provides a new way of thinking on the clinical management of diabetic nephropathy by combining Chinese and Western medicines.
文章引用:胡华, 陈秋. 基于《黄帝内经》“水郁折之”理论探讨糖尿病肾病[J]. 中医学, 2026, 15(2): 266-271. https://doi.org/10.12677/tcm.2026.152104

参考文献

[1] Alicic, R.Z., Rooney, M.T. and Tuttle, K.R. (2017) Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of the American Society of Nephrology, 12, 2032-2045. [Google Scholar] [CrossRef] [PubMed]
[2] ElSayed, N.A., McCoy, R.G., Aleppo, G., Balapattabi, K., Beverly, E.A., Briggs Early, K., et al. (2025) Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes 2025. Diabetes Care, 48, S239-S251. [Google Scholar] [CrossRef] [PubMed]
[3] 中华医学会糖尿病学分会. 中国糖尿病防治指南(2024版) [J]. 中华糖尿病杂志, 2025, 17(1): 16-139.
[4] de Boer, I.H., Khunti, K., Sadusky, T., Tuttle, K.R., Neumiller, J.J., Rhee, C.M., et al. (2022) Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care, 45, 3075-3090. [Google Scholar] [CrossRef] [PubMed]
[5] 徐韩博, 赵汝顺, 郝阳泉, 等. 从“水郁折之”辨治股骨头坏死并发骨髓水肿[J]. 中医学报, 2025, 40(5): 991-995.
[6] 许生, 黄笛, 夏娟娟, 等. 基于“水郁折之”探析《伤寒论》水郁治法[J]. 中医学报, 2020, 35(7): 1408-1411.
[7] 王传池, 胡镜清, 方锐, 等. “水郁折之”“析”辩[J]. 江苏中医药, 2015, 47(9): 5-6+9.
[8] 杨晗, 魏凤琴. 张珍玉从气机升降认知“水郁折之”理论及其临床意义[J]. 中国中医基础医学杂志, 2019, 25(10): 1433-1435.
[9] 曾静怡, 鲍晓荣. 糖尿病肾病发病机制的研究进展[J]. 中国中西医结合肾病杂志, 2021, 22(5): 461-463.
[10] 余江毅, 倪青, 刘苏. 糖尿病肾病病证结合诊疗指南[J]. 中医杂志, 2022, 63(2): 190-197.
[11] 周昱君, 彭良岳. 从浊毒病机理论探讨糖尿病肾病[J]. 中医临床研究, 2024, 16(14): 118-121.
[12] 张溢洋, 李志刚, 谷宁, 等. 从现代医学视角探析“肾主水”的涵义[J]. 中医学报, 2024, 1-14.
[13] 邢大庆, 韩履祺. 韩履祺教授从肝郁论治糖尿病肾病经验[J]. 中国中西医结合肾病杂志, 2023, 24(8): 667-668.
[14] 郭倩, 万生芳. 从黄元御“一气周流”理论论治糖尿病肾病[J]. 中医学报, 2024, 39(3): 480-483.
[15] 何一诺, 傅晓骏. 从脾不散精, 痰瘀互结论治糖尿病肾病[J]. 中医学报, 2024, 1-5.
[16] 朱翠翠. 杨辰华主任医师基于“肾络-玄府”理论治疗糖尿病肾病经验[J]. 中医研究, 2020, 33(8): 47-49.
[17] 中华中医药学会, 北京中医药大学东直门医院, 北京中医药大学. 糖尿病肾脏疾病中西医结合诊疗指南[J]. 北京中医药大学学报, 2024, 47(4): 580-592.
[18] 胡锦浩, 孙贵炎, 申鑫惠, 等. 基于“诸转反戾, 水液浑浊, 皆属于热”理论探讨复方益糖康调控糖尿病肾病“炎症因子”研究进展[J]. 辽宁中医药大学学报, 2024, 26(9): 199-205.
[19] 金恒伊, 杨宇峰, 石岩. 基于火神派从真武汤论治阳虚型糖尿病肾病[J]. 实用中医内科杂志, 2024, 38(9): 81-83.
[20] 鞠静, 杜武勋. 真武汤药效物质基础及温阳利水机制研究[J]. 吉林中医药, 2016, 36(7): 719-723.
[21] 操顺君, 郑承红. 从肾之“实证”论治早期糖尿病肾病[J]. 中西医结合研究, 2022, 14(5): 335-337.
[22] 谢慧敏, 魏月, 唐国娟, 等. 张法荣教授运用滋水清肝饮治疗糖尿病肾病经验举隅[J]. 亚太传统医药, 2017, 13(9): 91-92.
[23] 刘志伟, 安淑华, 叶春芳, 等. 疏肝理气方治疗早期糖尿病肾病患者及对血管内皮功能的影响[J]. 陕西中医, 2013, 34(12): 1603-1605.
[24] 周城, 杨宇峰, 安继仁, 等. 石岩基于“脾运转输平衡”理论从脾论治糖尿病肾病[J]. 辽宁中医杂志, 2024, 51(8): 59-61.
[25] 王志高. 加味参苓白术散治疗脾肾气虚兼瘀型早期糖尿病肾病25例疗效观察[J]. 河北中医, 2012, 34(9): 1339-1341.
[26] 王秀莹, 赵长松, 张文龙. 健脾泄浊解毒方治疗糖尿病肾病临床研究[J]. 陕西中医, 2025, 46(1): 68-71.
[27] 李艳春, 李嘉鑫, 杨宇峰, 等. 基于“五行相生相克”理论论治糖尿病肾病[J]. 中国实验方剂学杂志, 2021, 27(11): 240-245.
[28] 王钢, 周恩超, 易岚, 等. 邹氏肾科治肾学术传承及经验概要[J]. 南京中医药大学学报, 2024, 40(10): 1087-1096.
[29] 杨开来, 陈伟明, 向军. 金水宝胶囊对早期糖尿病肾病患者血液流变学及炎症因子的影响[J]. 浙江中西医结合杂志, 2019, 29(5): 375-377.
[30] 张帆, 刘伟敬, 郑慧娟, 等. 糖尿病肾病之六经辨证初探[J]. 环球中医药, 2021, 14(5): 835-840.
[31] 阙嘉露, 庞彩霞, 李方园, 等. 五苓散临床应用及现代机理研究进展[J]. 亚太传统医药, 2025, 21(6): 227-233.
[32] 马艳春, 周波, 宋立群, 等. 从痰瘀论治糖尿病肾病的理论探讨[J]. 中医药学报, 2010, 38(2): 86-88.
[33] 王诗尧, 王世东, 傅强, 等. 国医大师吕仁和“微型癥瘕”病理假说的源流及发展[J]. 中华中医药杂志, 2022, 37(8): 4555-4559.
[34] 贺璞玉, 倪青. 倪青治疗糖尿病肾病的思路与方法[J]. 中医药导报, 2022, 28(2): 184-187+192.
[35] 王静, 金丽霞, 张晓东, 等. 基于“去宛陈莝”理论探讨中西医结合防治老年糖尿病肾病的研究进展[J]. 中国老年学杂志, 2025, 45(7): 1773-1776.
[36] 李红典, 董少宁, 刘亚, 等. 基于补肾活血法的中西医结合治疗糖尿病肾病有效性及安全性的Meta分析[J]. 中草药, 2022, 53(6): 1810-1821.